- Prevention of complications of vaginal hysterectomy
Prevention of complications of vaginal hysterectomy
HEALTH OF WOMAN. 2017.6(122):119–123; doi 10.15574/HW.2017.122.119
Golyanovsky O. V., Gubar I. A., Kulchytsky D. V.
National Medical Academy of Postgraduate Education PL Shupika, Kyiv
Central District Hospital, Vyshgorod (Kyiv Region)
The article presents data on the improved technique of vaginal hysterectomy (GE) with the use of medications and technical support in case of genital prolapse.
The objective: was to determine the clinical effectiveness of preventive measures, the improved technique of vaginal GE in case of complete loss of the uterus with the use of drugs and technical support.
Patients and methods. The main group included 21 women with total uterine prolapse, who underwent vaginal GE without uterine appendages according to the procedure we improved, and in the control group – 17 women, who underwent vaginal GE with a standard procedure. In the two groups after the vaginal GE, anterior and posterior colpoperineoraphy was performed with levatoroplasty.
Results. We have improved the technique of conducting vaginal GE with the use of medications (hydroparreparation of the solution with 0.4 mg of terlipressin) and technical support (use of the radiofrequency scalpel and argon-plasma tissue coagulation), according to our study, significantly reduces the likelihood of intraoperative complications and improves postoperative period with respect to reparative Processes and a decrease in the frequency of hemorrhagic and pyoinflammatory diseases after surgery Skogen intervention.
Conclusion. The clinical study determined the effectiveness of a comprehensive surgical technique for the complete loss of the uterus and prevention of possible complications of surgical intervention.
Key words: vaginal hysterectomy, colpo-perineorrhaphy, levatoroplasty, synthetic analogue of vasopressin, argon-plasma coagulation of tissues.
1. Hlushko OI, Holianovskyi OV. 2011. Akusherska hipotonichna krovotecha: poshuk optymalnoi modeli likuvannia. Zdorove zhenshchynу 10:26-28.
2. Oleneva MA, Esipova LN, Vuchenovich YuD. 2010. Argonoplazmennaya koagulyatsiya tkaney pri kesarevom sechenii. Status Praesens. 2;4:61-64.
3. ACOG Committee Opinion No. 444: choosing the route of hysterectomy for benign disease. Obstet Gynecol. 2009, Nov. 114(5):1156-8.
4. Blikkendaal MD, Schepers EM, van Zwet EW, Twijnstra AR, Jansen FW. 2015, Oct. Hysterectomy in very obese and morbidly obese patients: a systematic review with cumulative analysis of comparative studies. Arch Gynecol Obstet. 292(4):723-38. https://doi.org/10.1007/s00404-015-3680-7; PMid:25773357 PMCid:PMC4560773
5. Clarke-Pearson DL, Geller EJ. 2013, Mar. Complications of hysterectomy. Obstet. Gynecol. 121(3):654-73. https://doi.org/10.1097/AOG.0b013e3182841594; PMid:23635631
6. Gupta J. 2015, Oct 7. Vaginal hysterectomy is the best minimal access method for hysterectomy. Evid. Based Med. https://doi.org/10.1136/ebmed-2015-110300; PMid:26446039
7. Grund KE, Straub T, Farin G. 1999. New haemostatic techniques: argon plasma coagulation. Baillieres Best PractRes Clin Gastroenterol. 13;1: 67–84. https://doi.org/10.1053/bega.1999.0009
8. Kovac SR. 2004, Aug. Clinical opinion: guidelines for hysterectomy. Am. J Obstet. Gynecol. 191(2):635-40. https://doi.org/10.1016/j.ajog.2004.05.080; PMid:15343253
9. Kulkarni MM, Rogers RG. 2010, Mar. Vaginal hysterectomy for benign disease without prolapse. Clin Obstet Gynecol. 53(1):5-16. https://doi.org/10.1097/GRF.0b013e3181cd3f0d; PMid:20142639
10. Landeen LB, Bell MC, Hubert HB, Bennis LY, Knutsen-Larson SS, Seshadri-Kreaden U. 2011, Jun. Clinical and cost comparisons for hysterectomy via abdominal, standard laparoscopic, vaginal and robot-assisted approaches. SD Med. 64(6):197-9, 201, 203 passim.
11. Lucero M, Shah AD. 2010, Mar. Vaginal hysterectomy for the prolapsed uterus. Clin Obstet Gynecol. 53(1):26-39. https://doi.org/10.1097/GRF.0b013e3181cd4065; PMid:20142641
12. Nieboer TE, Johnson N, Lethaby A, Tavender E, Curr E, Garry R et al. 2009, Jul 8. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev. CD003677.
13. Whiteman MK, Hillis SD, Jamieson DJ, Morrow B, Podgornik MN, Brett KM. 2008, Jan. Inpatient hysterectomy surveillance in the United States, 2000-2004. Am J Obstet Gynecol. 198(1):34.e1-7. https://doi.org/10.1016/j.ajog.2007.05.039; PMid:17981254
14. Wu JM, Wechter ME, Geller EJ, Nguyen TV, Visco AG. 2007, Nov. Hysterectomy rates in the United States, 2003. Obstet Gynecol. 110(5):1091-5. https://doi.org/10.1097/01.AOG.0000285997.38553.4b; PMid:17978124
15. Bump RC, Mattiasson A, Bo K et al. 1996. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 175(1):10-7. https://doi.org/10.1016/S0002-9378(96)70243-0